Drug Safety Settlement
Daiichi Sankyo says it was misled over Ranbaxy U.S. probes
Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the company hid information regarding U.S. regulatory probes into Ranbaxy. Full Article
- Gold slips after Bernanke hints at slowing bond buys
- FBI says man shot dead while being questioned about Boston bombings
- British soldier hacked to death in suspected Islamist attack
- Soldier hacked to death in London in suspected Islamist attack
- Short story writer Lydia Davis wins Man Booker International fiction prize
REUTERS SHOWCASE
Tax Avoidance
EU leaders talk tough on tackling Amazon, Google over taxes. Full Article | Related Story
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
MARKET EYE-NMDC gains as Barclays upgrade offsets auction price concerns
* Shares in Indian state-run miner NMDC Ltd gain 2.9 percent, recovering from an earlier fall of 2.7 percent, with Barclays' upgrade of the stock offsetting concerns over the auction floor price for the company's share issue. *Barclays raised NMDC to 'overweight' from 'underweight' late on Monday, citing favourable pricing dynamics in domestic iron ore markets. * The investment bank also raised its 12-month price target on NMDC to 210 rupees from 173 rupees. * Barclays said the falling domestic output of iron ore because of caps and restrictions in some Indian states could increase imports of the commodity, bringing domestic prices in line with seaborne prices. (abhishek.vishnoi@thomsonreuters.com /; abhishek.vishnoi.reuters.com@reuters.net)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints






Follow Reuters